• WKN: 707400
  • ISIN: DE0007074007
  • Land: Deutschland

Nachricht vom 03.07.2019 | 08:19

KWS SAAT SE & Co. KGaA: Dr. Hagen Duenbostel appointed Board Spokesman of KWS for a further five years

DGAP-News: KWS SAAT SE & Co. KGaA / Key word(s): Personnel

03.07.2019 / 08:19
The issuer is solely responsible for the content of this announcement.

Einbeck, July 03, 2019

Dr. Hagen Duenbostel appointed Board Spokesman of KWS for a further five years

The Supervisory Board of KWS SAAT SE has appointed Dr. Hagen Duenbostel as a member of the Executive Board and Board Spokesman for a further five years effective from January 1, 2020.

"Dr. Hagen Duenbostel has played a key role in shaping the company's development in his 17 years on the Executive Board. We're delighted to continue down our successful path with him," said Dr. Drs. h.c. Andreas J. Büchting, Chairman of the Supervisory Board, following the Supervisory Board's decision.

Duenbostel holds a doctorate in business management and has been a member of KWS' Executive Board since 2003. He was appointed Board Spokesman in 2015. The 49-year-old has special responsibility for Corn North and South America, Corn China/Asia, Strategy, Compliance, and Governance & Risk Management.

About KWS*
KWS is one of the world's leading plant breeding companies. In the fiscal year 2017/18 more than 5,000 employees in 70 countries generated net sales of EUR 1,068 million and earnings before interest and taxes (EBIT) of EUR 133 million. A company with a tradition of family ownership, KWS has operated independently for more than 160 years. It focuses on plant breeding and the production and sale of seed for corn, sugarbeet, cereals, rapeseed and sunflowers. KWS uses leading-edge plant breeding methods to increase farmers' yields and to improve resistance to diseases, pests and abiotic stress. To that end, the company invested almost EUR 200 million last fiscal year in research and development.
* All figures exclude the companies carried at equity AGRELIANT GENETICS LLC., AGRELIANT GENETICS INC. and KENFENG - KWS SEEDS CO., LTD.
For more information: Follow us on Twitter(R) at

Sina Barnkothe
Expert Corporate Communications
Phone +49-5561-311-1783



03.07.2019 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at

show this


MBH Corporation. Hohes Kurspotenzial

Die MBH Corporation plc hat in den vergangenen Berichtsperioden eine sehr hohe M&A-Aktivität aufgezeigt. Unter Anwendung der so genannten Agglomeration Methodology hat die Beteiligungsgesellschaft branchenübergreifend seit 2018 11 Beteiligungen erworben. Bei einem Pro-Forma-Umsatz der Beteiligungsgesellschaften von über 120 Mio. GBP und einem Pro-Forma-EBITDA in Höhe von über 11 Mio. GBP weist die MBH derzeit eine Marktkapitalisierung von umgerechnet gerade einmal 19,8 Mio. GBP auf. Ausgehend vom aktuellen Aktienkurs liegt zu unserem Kursziel in Höhe von 1,95 € ein hohes Kurspotenzial vor

News im Fokus

Deutsche Lufthansa AG: Lufthansa Finanzvorstand Ulrik Svensson legt aus gesundheitlichen Gründen sein Mandat nieder

04. April 2020, 15:11

Aktueller Webcast

SeaChange Corporation

Fourth Quarter Fiscal Year 2020 Results

06. April 2020

Aktuelle Research-Studie

FinLab AG

Original-Research: FinLab AG (von GBC AG): Kaufen

07. April 2020